Overview Fundamentals API Earnings EOD API Sample Code Pricing

POOLBEG PHARMA LS -0002 (7JN F) stock market data APIs

€0.138 0(0%) as of July 26, 2024
Price chart is built with Anychart

Poolbeg Pharma PLC operates as a biopharmaceutical company, engages in the development and commercialization of medicines for unmet medical needs in the United Kingdom. It develops POLB 001, which is in phase 1 clinical study for cancer immunotherapy-induced cytokine release syndrome and severe influenza. The company is also developing oral encapsulated GLP-1R agonist for obesity and diabetes treatment; influenza and respiratory syncytial virus AI programme; POLB 002, an in­licensed first­in­class broad spectrum RNA­based immunotherapy for respiratory virus infections; and POLB 003, an intramuscular vaccine to prevent Melioidosis. In addition, it has a license to encapsulation technology for oral vaccine delivery platform that delivers immune stimulating antigens to various areas of the gut. Further, the company is involved in the development of biomarker platform to identify those at risk of developing severe disease; and vaccine discovery platform, a model-derived discovery platform to identify new vaccine candidates. Poolbeg Pharma plc was incorporated in 2021 and is headquartered in London, the United Kingdom.

POOLBEG PHARMA LS -0002 Financial Data Overview

0.138
0.138
-
0.138
0.138
0.0645-0.175
72 639 K
500 M
0
2.186
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: '7JN',
Type: 'Common Stock',
Name: 'POOLBEG PHARMA LS -0002',
Exchange: 'F',
CurrencyCode: 'EUR',
CurrencyName: 'Euro',
CurrencySymbol: '€',
CountryName: 'Germany',
CountryISO: 'DE',
OpenFigi: NULL,
ISIN: 'GB00BKPG7Z60',
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
}

POOLBEG PHARMA LS -0002 Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA -4 660 000
  • Earnings Per Share -0.01
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get POOLBEG PHARMA LS -0002 Earnings via APIs

  • Latest Release NaN
  • EPS/Forecast NaN

Get POOLBEG PHARMA LS -0002 End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com